Aditx acquires Ignite Proteomics, LLC
Aditx agreed to acquire Ignite Proteomics, LLC. Reported deal value: $36M. Status: Announced. Sector: precision oncology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-03-13. Figures and status may change as filings and press coverage update.
Aditxt , Inc. , a social innovation platform accelerating promising health innovations, today announced the acquisition of Ignite Proteomics , LLC , a commercial-stage precision oncology company focused on addressing a critical challenge in cancer care : optimizing therapy selection
Deal timeline
This transaction is classified in precision oncology with a reported deal value of $36M. Figures and status may change as sources update.